Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

51.95
+0.11910.23%
Post-market: 51.950.00000.00%16:15 EDT
Volume:140
Turnover:7K
Market Cap:33.77M
PE:- -
High:51.95
Open:51.83
Low:51.95
Close:51.83
52wk High:58.24
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.06
T/O Rate:0.02%
Dividend:0.35
Dividend Rate:0.67%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Chewy Price Target Cut to $37.00/Share from $42.00 by Morgan Stanley

Dow Jones
·
Aug 26

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

Dow Jones
·
Aug 26

Chewy to Show Consistent Market Share Gains, Reaffirm 2026 Outlook During Q2 Print, RBC Says

MT Newswires Live
·
Aug 26

Freshpet CEO William B. Cyr Disposes of Common Shares Worth $6,044,496.41

Reuters
·
Aug 26

Wall Street Analysts Are Bullish on Top Consumer Cyclical Picks

TIPRANKS
·
Aug 26

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Aug 26

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
Aug 26

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Aug 25

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Aug 25

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
Aug 25

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
Aug 25

Freshpet (FRPT) Climbed, So What Is Drawing Attention Now?

Simply Wall St.
·
Aug 25

Revvity Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 25

Zoetis Files Form 3 for EVP, CFO and COO James Saccaro

Reuters
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24